Ceftriaxone Sodium Injection, Powder, For Solution
Product Images NDC 60505-6149

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Ceftriaxone Sodium (NDC 60505-6149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (001)

Chemical structure of Ceftriaxone Sodium illustrating its molecular components, including a beta-lactam ring, thiazole ring, and sodium salt groups, as labeled in the product data for the injection powder form.*

FDA Label Image

Ceftriaxone For Injection 250 mg Label (002)

Label for Ceftriaxone Sodium Injection, USP 250 mg per vial, single-use vial for intramuscular or intravenous use. The label includes storage instructions, manufacturer Apotex Corp., and a 2D barcode area. It also displays lot, expiration, and GTIN placeholders, along with barcodes on the right side.*

FDA Label Image

Ceftriaxone For Injection 500 mg Label (003)

Label for Ceftriaxone Injection USP 500 mg/vial, an injection powder for solution by Apotex Corp. It is a single-use vial for intramuscular or intravenous use. The label includes storage instructions, dosage references, manufacturing details, and a 2D code area with placeholders for lot number, expiration date, and GTIN.*

FDA Label Image

Ceftriaxone For Injection 1 G Label (004)

Label for Ceftriaxone Sodium injection, USP, 1 g per vial, single-use vial for intramuscular or intravenous use. The label shows Apotex Corp. as the labeler, includes storage and usage instructions, and contains sections for lot number, expiration date, and GTIN. The NDC number 60505-6148-0 is displayed.*

FDA Label Image

Ceftriaxone For Injection 2 G Label (005)

Label for Ceftriaxone for Injection USP, 2 g per vial, powder for solution injection by Apotex Corp. The single-use vial is for intramuscular or intravenous use. The label includes storage instructions prior to reconstitution at 20° to 25°C, dosage and usage directions referencing the package insert, and identifies the manufacturer and labeler. Barcode and placeholder areas for lot number, expiration date, and GTIN are also shown.*

FDA Label Image

006

Ceftriaxone Sodium 250 mg/vial injection, powder for solution, single-use vial packaging label. The label shows it is for intramuscular or intravenous use. It includes instructions for reconstitution, storage conditions, and manufacturer details: Qilu Pharmaceutical Co. and Apotex Corp. The NDC is 60505-6151-4, and the package contains one 250 mg vial.*

FDA Label Image

007

Packaging label for Ceftriaxone Sodium injection, USP, 250 mg per vial, in powder form for solution. The label indicates 10 single-use vials of 250 mg each for intramuscular or intravenous use. Manufactured by Apotex Corp., the label includes dosage form, usage instructions, storage information, and lot details with a barcode.*

FDA Label Image

008

Label for Ceftriaxone for Injection USP 500 mg/vial single-use vial by Apotex Corp. The label includes dosage form as injection powder for solution, intramuscular or intravenous use, and contains detailed preparation instructions. Storage information and manufacturing details for Qilu Pharmaceutical Co., Ltd. are also included along with the NDC 60505-6152-4.*

FDA Label Image

009

Packaging label for Ceftriaxone for Injection, USP, 500 mg per vial. The label indicates single-use vials, 10 vials per package, for intramuscular or intravenous use. Manufactured by Apotex Corp. The label includes dosage instructions and storage information, with the NDC 60505-6152-1 visible.*

FDA Label Image

010

Label for Ceftriaxone Sodium Injection, USP 1 g/vial by Apotex Corp., presented in 10 single-use vials. The product is a powder for solution intended for intramuscular or intravenous use. The label includes storage instructions, manufacturer information, and dosing preparation details.*

FDA Label Image

011

Packaging label for Ceftriaxone 2 g/vial Injection, USP powder for solution. The box contains 10 single-use vials for intramuscular or intravenous use. Labeler is Apotex Corp. The label includes usage directions and storage instructions with a batch and barcode area.*

FDA Label Image

012

Packaging label for Ceftriaxone for Injection, USP 1 g/vial powder for solution, by Apotex Corp. It is a 1 g single-use vial for intramuscular or intravenous use. The label includes usage directions, storage instructions, lot and expiration details, and manufacturer information. The NDC is 60505-6148-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.